Submission Details
| 510(k) Number | K232573 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 25, 2023 |
| Decision Date | November 21, 2023 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K232573 is an FDA 510(k) clearance for the INFINITI? Ambi Angiographic Catheter, a Catheter, Intravascular, Diagnostic (Class II — Special Controls, product code DQO), submitted by Cordis US Corp (Miami Lakes, US). The FDA issued a Cleared decision on November 21, 2023, 88 days after receiving the submission on August 25, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1200.
| 510(k) Number | K232573 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 25, 2023 |
| Decision Date | November 21, 2023 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQO — Catheter, Intravascular, Diagnostic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1200 |